{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:40:49Z","timestamp":1781703649195,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clinbiochem.2025.110995","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:26:19Z","timestamp":1755822379000},"page":"110995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Defining a clinically relevant thyroglobulin antibody interference threshold for high-sensitivity thyroglobulin immunoassays: a single institution case study"],"prefix":"10.1016","volume":"139","author":[{"given":"Simmi","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavia M.","family":"Peck Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanda B.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Mulvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Shurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-9836","authenticated-orcid":false,"given":"Sarah E.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2025.110995_b0005","unstructured":"SEER. National Cancer Institute Surveillance Research Program SEER*Stat Databases. Published online November 2020. https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2018\/index.htm."},{"issue":"18","key":"10.1016\/j.clinbiochem.2025.110995_b0010","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110995_b0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MED.0000000000000092","article-title":"How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies","volume":"21","author":"Spencer","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110995_b0020","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1093\/ejendo\/lvad109","article-title":"Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus","volume":"189","author":"Giovanella","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110995_b0025","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-14-0148","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper","volume":"171","author":"Giovanella","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.110995_b0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/thy.2012.0606","article-title":"Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement","volume":"23","author":"Verburg","year":"2013","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110995_b0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ncpendmet0757","article-title":"Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer","volume":"4","author":"Spencer","year":"2008","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110995_b0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2013.07.003","article-title":"Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer","volume":"27","author":"Spencer","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110995_b0045","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac169","article-title":"thyroglobulin assay interferences: clinical usefulness of mass-spectrometry methods","volume":"7","author":"Barbesino","year":"2022","journal-title":"J. Endocr. Soc."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110995_b0050","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0137","article-title":"Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma","volume":"11","author":"Dekker","year":"2022","journal-title":"Eur Thyroid J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110995_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/thy.2018.0195","article-title":"Clinical applicability of low levels of thyroglobulin autoantibodies as cutoff point for thyroglobulin autoantibody positivity","volume":"29","author":"Dekker","year":"2019","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110995_b0060","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1210\/jc.2010-2762","article-title":"Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low\/undetectable serum Tg IMA values for patients with differentiated thyroid cancer","volume":"96","author":"Spencer","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110995_b0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/105072503322240013","article-title":"Thyroglobulin autoantibody levels below the cut-off for positivity can interfere with thyroglobulin measurement","volume":"13","author":"Cubero","year":"2003","journal-title":"Thyroid"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T13:31:48Z","timestamp":1766842308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":13,"alternative-id":["S0009912025001249"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110995","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining a clinically relevant thyroglobulin antibody interference threshold for high-sensitivity thyroglobulin immunoassays: a single institution case study","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110995"}}